You have 9 free searches left this month | for more free features.

Repeat dose

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)

Active, not recruiting
  • Alcohol Use Disorder
  • Glendale, California
    Parexel Los Angeles Early Phase Clinical Unit
Apr 26, 2023

Chronic Pain Trial (ST-01, 1% Lidocaine HCL)

Not yet recruiting
  • Chronic Pain
  • (no location specified)
Jan 27, 2023

Healthy Participants Trial in Glendale, Brooklyn, Berlin (AZD6234, Placebo)

Not yet recruiting
  • Healthy Participants
  • Glendale, California
  • +2 more
Nov 10, 2023

Pulmonary Disease, Chronic Obstructive Trial (GSK3923868, Placebo)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
Jan 9, 2023

Postbariatric Hypoglycemia Trial (Mizagliflozin)

Not yet recruiting
  • Postbariatric Hypoglycemia
  • (no location specified)
Jan 31, 2023

Atopic Dermatitis Trial in Glendale (UCB1381, Placebo)

Recruiting
  • Atopic Dermatitis
  • UCB1381
  • Placebo
  • Glendale, California
    Up0110 101
Jan 20, 2023

Post Operative Pain, Acute Trial in Vejle (Dexamethasone 24 mg, Placebo)

Recruiting
  • Post Operative Pain, Acute
  • Dexamethasone 24 mg
  • Placebo
  • Vejle, Denmark
    Vejle Hospital. Orthopedic Surgery Department. Clinical Research
Oct 12, 2022

Colitis, Ulcerative Trial in Cambridge (GSK4381406, Placebo, Indomethacin)

Not yet recruiting
  • Colitis, Ulcerative
  • Cambridge, United Kingdom
    GSK Investigational Site
Aug 11, 2023

Acute Kidney Injury, HIE Trial in Oklahoma City (Single Dose Theophylline, Repeat Dose Theophylline, Placebo)

Not yet recruiting
  • Acute Kidney Injury
  • HIE
  • Single Dose Theophylline
  • +2 more
  • Oklahoma City, Oklahoma
    University of Oklahoma Health Sciences Center
May 2, 2023

Healthy Volunteers Trial (Elafibranor)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
Sep 14, 2022

Healthy Trial in Miami (CORT125134 150 mg, CORT125134 250 mg, CORT125134 dose to be determined)

Completed
  • Healthy
  • CORT125134 150 mg
  • +2 more
  • Miami, Florida
    Quotient Sciences, Miami, Inc.
Oct 17, 2023

Drug Kinetics, Drug Effects on Physiology Trial in Mount-Royal (sargramostim)

Completed
  • Drug Kinetics
  • Drug Effects on Physiology
  • sargramostim
  • Mount-Royal, Quebec, Canada
    AltaSciences
Sep 30, 2022

Lumbosacral Radicular Pain Trial in Boise (SP-102)

Completed
  • Lumbosacral Radicular Pain
  • Boise, Idaho
    Semnur Research Site 1
Jan 5, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Seoul ([177Lu]Ludotadipep)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer, mCRPC
  • Seoul, Korea, Republic of
    The Catholic University of Korea, Seoul, St, Mary's Hospital, 22
Dec 8, 2022

Healthy, Botulinum Toxin Trial in United States (G03-52-01, Placebo)

Recruiting
  • Healthy
  • Botulinum Toxin
  • Mobile, Alabama
  • +14 more
Aug 3, 2022

Acute Repetitive Seizures, Breakthrough Seizures Trial in United States (NRL-1)

Completed
  • Acute Repetitive Seizures
  • Breakthrough Seizures
  • Little Rock, Arkansas
  • +4 more
Jan 27, 2022

Metastatic Castration-resistant Prostate Cancer Trial ([177Lu]Ludotadipep 3.7 GBq)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • [177Lu]Ludotadipep 3.7 GBq
  • (no location specified)
Jul 12, 2022

Pulmonary Disease, Chronic Obstructive Trial in Cambridge (GSK3923868, Matching , Monodose RS01)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Cambridge, United Kingdom
    GSK Investigational Site
Sep 26, 2022

Schizophrenia Trial in Garden Grove, Gaithersburg, Marlton (Iloperidone)

Recruiting
  • Schizophrenia
  • Garden Grove, California
  • +2 more
Jun 1, 2022

Rheumatoid Arthritis Trial in Los Angeles, Tustin, Miami (Low dose ORTD-1, Low dose vehicle control, High dose ORTD-1)

Completed
  • Rheumatoid Arthritis
  • Low dose ORTD-1
  • +3 more
  • Los Angeles, California
  • +2 more
Oct 15, 2021

Acute Repetitive Seizures Trial in United States (NRL-1)

Completed
  • Acute Repetitive Seizures
  • Saint Louis, Missouri
  • +3 more
Sep 8, 2021

Pulmonary Disease, Chronic Obstructive Trial (GSK3923868, Placebo)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
May 26, 2022

Paroxysmal Atrial Fibrillation (PAF) Trial in Belgium, Netherlands (Flecainide Acetate)

Completed
  • Paroxysmal Atrial Fibrillation (PAF)
  • Flecainide Acetate
  • Bonheiden, Belgium
  • +8 more
Dec 2, 2022

Healthy Trial in London (ETD002 - single dose, Placebo - single dose, ETD002 - 7 day repeat dose)

Completed
  • Healthy
  • ETD002 - single dose
  • +6 more
  • London, United Kingdom
    Hammersmith Medicines Research
May 20, 2021